Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cassava Sciences Inc (NQ: SAVA )

23.23 +0.71 (+3.15%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 704,366
Open 22.79
Bid (Size) 23.00 (10)
Ask (Size) 23.25 (3)
Prev. Close 22.52
Today's Range 22.55 - 23.33
52wk Range 13.84 - 51.59
Shares Outstanding 41,749,435
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cassava Sciences to Present at the Jefferies Global Healthcare Conference
From Cassava Sciences, Inc.
Via GlobeNewswire
3 Biotech Stocks to Avoid Like the Plague
Investors are looking for bargains in the biotech sector. But these three biotech stocks should be avoided at all costs. 
Via InvestorPlace

Performance

YTD
-16.32%
-16.32%
1 Month
+3.98%
+3.98%
3 Month
-11.64%
-11.64%
6 Month
-31.15%
-31.15%
1 Year
-20.06%
-20.06%

More News

Read More
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Hero or Zero? 7 High-Risk Stocks to Make You Rich… Or Broke.
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why Shares of Cassava Sciences Jumped This Week
Via The Motley Fool
Why Is Cassava Sciences (SAVA) Stock Up 15% Today?
Via InvestorPlace
Cassava Sciences Completes Patient Dosing in a Randomized Controlled Trial of Simufilam in Alzheimer’s Disease
From Cassava Sciences, Inc.
Via GlobeNewswire
Top 5 Health Care Stocks That May Collapse In Q2
Via Benzinga
New Data by Academic Researchers Highlights Biological Activity of Simufilam on Filamin A
From Cassava Sciences, Inc.
Via GlobeNewswire
Cassava Sciences Reports Q1 2023 Financial Results and Operating Updates
From Cassava Sciences, Inc.
Via GlobeNewswire
3 Big Reasons to Sell Cassava Sciences Stock Right Now
Via The Motley Fool
Cassava Sciences to Present at the 2023 H.C. Wainwright Investor Conference
From Cassava Sciences, Inc.
Via GlobeNewswire
Short Interest Sector Focus: Healthcare Sector
Via Benzinga
Why Is Asana (ASAN) Stock Up 24% Today?
Via InvestorPlace
ETSY Stock Falls on Double Downgrade
Via InvestorPlace
3 Short-Squeeze Stocks to Keep on Your Radar
Via InvestorPlace
Insider Richard Barry Is Betting Big on Cassava (SAVA) Stock
Via InvestorPlace
Why Cassava Sciences Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Tesla, Apple, Cassava Sciences, MongoDB, Asana: Why These Five Stocks Are Drawing Investors' Attention Today?
Via Benzinga
Why Cassava Sciences Stock Is Surging After Hours
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Cassava Sciences Reports Full-year 2022 Financial Results and Operating Updates
From Cassava Sciences, Inc.
Via GlobeNewswire
3 Drug Stocks to Watch as Alzheimer’s Clinical Trials End
Via InvestorPlace
Cassava Sciences Announces Patient Enrollment Update for Phase 3 Studies of Simufilam for the Treatment of Alzheimer’s Disease
From Cassava Sciences, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.